Parkinsonism-dementia and amyotrophic lateral sclerosis of Guam. Effect of probenecid on monoamine catabolite levels in cerebrospinal fluid.
D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000134:cerebrospinal fluid* / Q000453:epidemiology / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid* / Q000378:metabolism; D008297:Male; D001523:Mental Disorders / Q000134:cerebrospinal fluid* / Q000378:metabolism; D008849:Micronesia; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000453:epidemiology / Q000378:metabolism; D010648:Phenylacetates / Q000134:cerebrospinal fluid* / Q000378:metabolism; D011339:Probenecid / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism
D010648:Phenylacetates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid; D004298:Dopamine